下一个

自动播放

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

23 意见 • 07/30/23
分享
嵌入
administrator
administrator
订户
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放